ArticleMolecular therapy oncolytics2022

Inhibition of MEK-ERK pathway enhances oncolytic vaccinia virus replication in doxorubicin-resistant ovarian cancer.

Seoyul Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.